Skip to content

Clinical trials

Phase 2 Hematologic Diseases trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Phase: Phase 2 Country / region: Denmark Clear all

3 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20151
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Copenhagen University Hospital at Herlev1
Novartis Pharmaceuticals1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases3
Leukemia2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive2
Leukemia, Myeloid2
Bone Marrow Diseases1
Leukemia, Myeloid, Chronic-Phase1
Myeloproliferative Disorders1
Neoplasms1
Neoplasms by Histologic Type1
Polycythemia1

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.